Assessing the Impact of Covariate Distribution and Positivity Violation on Weighting-Based Indirect Comparisons: a Simulation Study
By: Arnaud Serret-Larmande , Jérôme Lambert , Stéphane Gaudry and more
Potential Business Impact:
Helps doctors compare treatments when data is tricky.
Population-Adjusted Indirect Comparisons (PAICs) are used to estimate treatment effects when direct comparisons are infeasible and individual patient data (IPD) are only available for one trial. Among PAIC methods, Matching-Adjusted Indirect Comparison (MAIC) is the most widely used. However, little is known about how MAIC performs under challenging conditions such as limited covariate overlap or markedly non-normal covariate distributions. We conducted a Monte Carlo simulation study comparing three estimators: (i) MAIC matching first moment (MAIC-1), (ii) MAIC matching first and second moments (MAIC-2), and (iii) a benchmark method leveraging full IPD -- Propensity Score Weighting (PSW). We examined eight scenarios ranging from ideal conditions to situations with positivity violations and non-normal (including bimodal) covariate distributions. We assessed both anchored and unanchored estimators and examined the impact of adjustment model misspecification. We also applied these estimators to real-world data from the AKIKI and AKIKI-2 trials, comparing renal replacement therapy strategies in critically ill patients. MAIC-1 demonstrated robust performance, remaining unbiased in the presence of moderate positivity violations and non-normal covariates, while MAIC-2 and PSW appeared more sensitive to positivity violations. All methods showed substantial bias when key confounders were omitted, emphasizing the importance of correct model specification. In real-world data, a consistent trend was found with MAIC-1 showing narrower confidence intervals with positivity violation. Our findings support the cautious use of unanchored MAICs and highlight MAIC-1's resilience across moderate violations of assumptions. However, the method's limited flexibility underscores the need for careful use in real-world settings.
Similar Papers
Arbitrated Indirect Treatment Comparisons
Machine Learning (Stat)
Finds the best medicine by comparing studies fairly.
Doubly robust augmented weighting estimators for the analysis of externally controlled single-arm trials and unanchored indirect treatment comparisons
Methodology
Improves drug testing when real trials aren't possible.
Balancing Weights for Causal Mediation Analysis
Methodology
Improves how we understand what causes what.